BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 4353187)

  • 21. [Messenger role of 3'5' adenosine monophosphoric acid (cyclic AMP) in the action of somatotropic hormone on the uptake of 14C glucose by the diaphragm of hypophysectomized rats].
    Buneaux JJ; Gounelle JC; Raoul Y
    J Physiol (Paris); 1972 Oct; 65():Suppl:206A-207. PubMed ID: 4346476
    [No Abstract]   [Full Text] [Related]  

  • 22. [Factors determining urinary excretion of cyclic 3',5' AMP].
    Janiec W
    Pol Tyg Lek; 1972 Sep; 27(39):1534-6. PubMed ID: 4343652
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibition of adenosine 3',5'-monophosphate accumulation in anterior pituitary gland in vitro by growth hormone-release inhibiting hormone.
    Borgeat P; Labrie F; Drouin J; Bélanger A; Immer H; Sestanj K; Nelson V; Götz M; Schally AV; Coy DH; Coy EJ
    Biochem Biophys Res Commun; 1974 Feb; 56(4):1052-9. PubMed ID: 4363638
    [No Abstract]   [Full Text] [Related]  

  • 24. Stimulation of cyclic AMP accuulation in the rat anterior pituitary in vitro by analogs of luteinizing hormone-releasing hormone.
    Lippmann W
    Experientia; 1975 Apr; 31(4):403-4. PubMed ID: 164365
    [No Abstract]   [Full Text] [Related]  

  • 25. [Regulation of cyclic AMP and cyclic GMP-dependent protein kinase activity].
    Szmigielski A
    Postepy Hig Med Dosw; 1980; 34(4):287-306. PubMed ID: 6270641
    [No Abstract]   [Full Text] [Related]  

  • 26. Thyrotropin-releasing hormone stimulation and somatostatin inhibition of growth hormone secretion from perfused rat adenohypophyses.
    Carlson HE; Mariz IK; Daughaday WH
    Endocrinology; 1974 Jun; 94(6):1709-13. PubMed ID: 4364640
    [No Abstract]   [Full Text] [Related]  

  • 27. Phosphodiesterase activity of rat and human adipose tissue.
    Solomon SS
    J Lab Clin Med; 1972 Apr; 79(4):598-610. PubMed ID: 4336560
    [No Abstract]   [Full Text] [Related]  

  • 28. [Ultrastructural study of anterior pituitary secretion].
    Pelletier G
    Union Med Can; 1973 Mar; 102(3):546-50. PubMed ID: 4351569
    [No Abstract]   [Full Text] [Related]  

  • 29. The chemistry and biological properties of nucleotides related to nucleoside 3',5'-cyclic phosphates.
    Simon LN; Shuman DA; Robins RK
    Adv Cyclic Nucleotide Res; 1973; 3():225-353. PubMed ID: 4357644
    [No Abstract]   [Full Text] [Related]  

  • 30. Heat treatment of rat liver denosine 3':5'-monophosphate phosphodiesterase. Kinetic characterization of the low affinity enzyme.
    Bevers MM; Smits RA; van Rijn J; van Wijk R
    Biochim Biophys Acta; 1974 Mar; 341(1):120-8. PubMed ID: 4364114
    [No Abstract]   [Full Text] [Related]  

  • 31. A kinetic analysis of the cyclic nucleotide phosphodiesterase regulation by the endogenous protein activator. A study of rat brain and frog sympathetic chain.
    Uzunov P; Lehne R; Revuelta AV; Gnegy ME; Costa E
    Biochim Biophys Acta; 1976 Feb; 422(2):326-34. PubMed ID: 174744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphodiesterase activity in muscles of control and dystrophic mice.
    Garbagna L; Cojazzi M; Marcucci F; Mussini E
    Res Commun Chem Pathol Pharmacol; 1981 Mar; 31(3):537-44. PubMed ID: 6265991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclic nucleotide phosphodiesterase 5 and sildenafil: promises realized.
    Manganiello V
    Mol Pharmacol; 2003 Jun; 63(6):1209-11. PubMed ID: 12761329
    [No Abstract]   [Full Text] [Related]  

  • 34. Synthesis and biological activity of some purine 5'-thio-5'-deoxynucleoside 3',5'-cyclic phosphorothioates.
    Shuman DA; Miller JP; Scholten MB; Simon LN; Robins RK
    Biochemistry; 1973 Jul; 12(15):2781-6. PubMed ID: 4352485
    [No Abstract]   [Full Text] [Related]  

  • 35. Thyrotropin release in vitro: stimulation by cyclic 3',5'-Adenosine monophosphate.
    Wilber JF; Peake GT; Utiger RD
    Endocrinology; 1969 Apr; 84(4):758-60. PubMed ID: 4304031
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of insulin and growth hormone on rat liver cyclic nucleotide phosphodiesterase.
    Thompson WJ; Little SA; Williams RH
    Biochemistry; 1973 May; 12(10):1889-94. PubMed ID: 4350103
    [No Abstract]   [Full Text] [Related]  

  • 37. Multiple molecular forms of phosphodiesterase: an overview.
    Weishaar RE
    J Cyclic Nucleotide Protein Phosphor Res; 1986-1987; 11(7):463-72. PubMed ID: 2831256
    [No Abstract]   [Full Text] [Related]  

  • 38. Studies on the phosphodiesterase in various organs of rats and guinea-pigs of different ages and different sex.
    Petkov V; Stancheva S
    Acta Physiol Pharmacol Bulg; 1977; 3(1):38-45. PubMed ID: 197791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analogues of adenosine 3',-5'-cyclic phosphate as activators of phosphorylase b kinase and as substrates for cyclic 3',5'-nucleotide phosphodiesterase.
    Drummond GI; Powell CA
    Mol Pharmacol; 1970 Jan; 6(1):24-30. PubMed ID: 4354004
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of systematic muscular work on the tissue activity of adenylate cyclase and 3',5'-AMP-phosphodiesterase].
    Iakovlev NN
    Ukr Biokhim Zh; 1974; 46(1):18-24. PubMed ID: 4363030
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.